Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–13 of 13 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT04947618
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- CHU Nimes Nîmes, Gard, France
Completed
Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
NCT00619879
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +27 more
- Locations
-
- Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
NCT02916979
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +24 more
- Locations
-
- Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
Completed
A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma
NCT01432951
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guangzhou, China
Completed
A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin
NCT01388335
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bordeaux, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dijon, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lille, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Paris, France
NCT00509184
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Charité Campus Mitte Berlin, Germany
- Charité Campus Benjamin-Franklin Berlin, Germany
- Charité Campus Buch Berlin, Germany
- University of Cologne Cologne, Germany
NCT02249429
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Weill Cornell Medicine New York, United States
- University Clinical Center Republic of Srpska Banja Luka, Bosnia and Herzegovina
- University Clinical Center Sarajevo Sarajevo, Bosnia and Herzegovina
- Insitute Curie Saint-Cloud, Paris, France
NCT00600353
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
- Locations
-
- University of Kansas Medical Center Kansas City, Kansas, United States
NCT00078637
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- San Antonio, Texas, United States
NCT00146055
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +21 more
- Locations
-
- The University of Michigan Ann Arbor, Michigan, United States
NCT00741871
- Conditions
- B Cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +12 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT00037791
- Conditions
- Blood Platelet Disorders, Blood Protein Disorders, Cardiovascular Diseases, +18 more
- Locations
-
- Pfizer Investigational Site Berkeley, California, United States
- Pfizer Investigational Site La Jolla, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
Active, Not Recruiting
DS-3201b in Participants With Lymphomas
NCT02732275
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- City of Hope National Medical center Duarte, California, United States
- Yale University New Haven, Connecticut, United States
- Emory University Atlanta, Georgia, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States